The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond

By afschroeder • May 1, 2026

Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond. J Nucl Med. 2026 Apr 30:jnumed.126.272026. doi: 10.2967/jnumed.126.272026. Epub ahead of print. PMID: 42061947.

Tags: 505(b)(2), Cedars Sinai DoM, Hematology/Oncology, lexicon, oncology, Publications, radiopharmaceutical therapy, regulatory

A 20-minute, free-running, whole-heart cardiac MRI to image myocardial injury following reperfused myocardial infarction: demonstration in a large animal model

Zhang X, Yang HJ, Huang Y, Yoosefian G, Vora K, Youssef K, Wilk B, Christodoulou AG, Li D, Sharif B, Prato FS, Kumar A, Dharmakumar[...]

A contemporary approach to diagnosis and treatment of right heart thrombus associated with pulmonary embolism

Matusov Y, Dohad S, Megna D Jr, Ranade M, Yaqoob M, Vintch JRE. A contemporary approach to diagnosis and treatment of right heart thrombus associated[...]

Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic Breast Cancer: A Brief Report of a Clinical Trial

Henneghan A, Wertheimer J, Kim S, Gresham G, Shirazipour CH, Jones B, Asher A. Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic[...]